Lannett Company
LCI
$0.69
Share price
0.00%
Change (1 day)
-69.93%
Change (1 year)
Categories
Lannett Company (LCI) - P/B ratio
P/B ratio as of May 2024 : -0.0179
According to Lannett Company's latest financial reports the company has a price-to-book ratio of -0.0179.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lannett Company - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | -0.0700 | -87.42% |
| 2021-12-31 | -0.5561 | -126.44% |
| 2020-12-31 | 2.10 | 100.39% |
| 2019-12-31 | 1.05 | 82.69% |
| 2018-12-31 | 0.5746 | -61.06% |
| 2017-12-31 | 1.48 | -3.37% |
| 2016-12-31 | 1.53 | -42.62% |
| 2015-12-31 | 2.66 | -34.01% |
| 2014-12-31 | 4.03 | -17.5% |
| 2013-12-31 | 4.89 | 309.96% |
| 2012-12-31 | 1.19 | 2.11% |
| 2011-12-31 | 1.17 | -21.23% |
| 2010-12-31 | 1.48 | -16.35% |
| 2009-12-31 | 1.77 | 6.13% |
| 2008-12-31 | 1.67 | 56.7% |
| 2007-12-31 | 1.07 | -44.15% |
| 2006-12-31 | 1.91 | -21.59% |
| 2005-12-31 | 2.43 | 7.13% |
| 2004-12-31 | 2.27 | -80.44% |
| 2003-12-31 | 11.6 | -19.39% |
| 2002-12-31 | 14.4 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.22 | -29,277.66% | 🇺🇸 USA |
 Novartis NVS | 4.99 | -27,985.45% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.76 | -9,951.53% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.74 | -26,603.47% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.45 | -30,517.59% | 🇬🇧 UK |